BiotechTube

Isavuconazonium sulfate + Isavuconazonium sulfate

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Invasive Mucormycosis

Conditions

Invasive Mucormycosis, Invasive Aspergillosis

Trial Timeline

Aug 22, 2019 → Dec 14, 2022

NCT ID
NCT03816176

About Isavuconazonium sulfate + Isavuconazonium sulfate

Isavuconazonium sulfate + Isavuconazonium sulfate is a phase 2 stage product being developed by Astellas Pharma for Invasive Mucormycosis. The current trial status is completed. This product is registered under clinical trial identifier NCT03816176. Target conditions include Invasive Mucormycosis, Invasive Aspergillosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03816176Phase 2Completed

Competing Products

20 competing products in Invasive Mucormycosis

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
41
pegylated liposomal doxorubicin (PLD) + PD-1CSPC Pharmaceutical Group LimitedPhase 2
51
Trastuzumab deruxtecan + DurvalumabDaiichi SankyoPhase 2
52
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
77
Micafungin + fluconazoleAstellas PharmaPhase 3
77
MicafunginAstellas PharmaPre-clinical
23
Micafungin (Mycamine)Astellas PharmaPhase 1
33
Pudexacianinium chlorideAstellas PharmaPhase 2
52
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
52
Enfortumab Vedotin + PembrolizumabAstellas PharmaPhase 2
52
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
23
Pembrolizumab + Enfortumab VedotinAstellas PharmaPhase 3
77
Micafungin + Systemic antifungal therapyAstellas PharmaPhase 2
52
MicafunginAstellas PharmaPre-clinical
23
Micafungin + PlaceboAstellas PharmaPhase 3
77
MicafunginAstellas PharmaApproved
85
Olorofim + AmBisome®ShionogiPhase 3
77
Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel + Epirubicin or doxorubicin, cyclophosphamide, paclitaxelJiangsu Hengrui MedicinePhase 3
77
SHR-A1811 + Trastuzumab EmtansineJiangsu Hengrui MedicinePhase 3
77
Herombopag tablets + Herombopag placebo tabletsJiangsu Hengrui MedicinePhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85